NCT01222624 2021-05-20PankoMab-GEXâ„¢: Phase 1 Dose Escalation StudyGlycotope GmbHPhase 1 Completed74 enrolled
NCT01899599 2020-10-22PankoMab-GEXâ„¢ Versus Placebo as Maintenance Therapy in Advanced Ovarian CancerGlycotope GmbHPhase 2 Completed216 enrolled